The present volume gives a comprehensive overview on the current state of basic and clinical research on Anxiety and Anxiolytic Drugs. Using newly developed methods and techniques researchers are now beginning to understand the molecular mechanisms of anxiety, anxiety disorders and their treatment. In parallel, new drug targets have been generated and the first clinical studies with new compounds have been started. In 20 chapters written by numerous experts in the field comprehensive information on all relevant topics is provided.
Or split into 4x interest-free payments of 25% on orders over R50
Learn more
The present volume gives a comprehensive overview on the current state of basic and clinical research on Anxiety and Anxiolytic Drugs. Using newly developed methods and techniques researchers are now beginning to understand the molecular mechanisms of anxiety, anxiety disorders and their treatment. In parallel, new drug targets have been generated and the first clinical studies with new compounds have been started. In 20 chapters written by numerous experts in the field comprehensive information on all relevant topics is provided.
Imprint | Springer-Verlag |
Country of origin | Germany |
Series | Handbook of Experimental Pharmacology, 169 |
Release date | June 2005 |
Availability | Expected to ship within 12 - 17 working days |
First published | 2005 |
Editors | Florian Holsboer, Andreas Stroehle |
Dimensions | 235 x 155 x 31mm (L x W x T) |
Format | Hardcover |
Pages | 566 |
Edition | 2005 ed. |
ISBN-13 | 978-3-540-22568-3 |
Barcode | 9783540225683 |
Categories | |
LSN | 3-540-22568-4 |